Behavior of edoxaban in patients with nonvalvular atrial fibrillation and heart failure in Spain. EMAYI studio.
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: SPANISH SOCIETY OF CARDIOLOGY
- Execution start: 22/01/2021
- End of execution: 30/08/2022
- PI: JESUS GABRIEL SANCHEZ RAMOS